Suppr超能文献

溶质载体家族SLC10:就功能和系统发育关系而言,不止是一个胆汁酸转运体家族。

The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.

作者信息

Geyer J, Wilke T, Petzinger E

机构信息

Institut für Pharmakologie und Toxikologie, Justus-Liebig-Universität Giessen, Frankfurter Strasse 107, 35392, Giessen, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):413-31. doi: 10.1007/s00210-006-0043-8. Epub 2006 Mar 16.

Abstract

The solute carrier family 10 (SLC10) comprises two sodium-dependent bile acid transporters, i.e. the Na(+)/taurocholate cotransporting polypeptide (NTCP; SLC10A1) and the apical sodium-dependent bile acid transporter (ASBT; SLC10A2). These carriers are essentially involved in the maintenance of the enterohepatic circulation of bile acids mediating the first step of active bile acid transport through the membrane barriers in the liver (NTCP) and intestine (ASBT). Recently, four new members of the SLC10 family were described and referred to as P3 (SLC10A3), P4 (SLC10A4), P5 (SLC10A5) and sodium-dependent organic anion transporter (SOAT; SLC10A6). Experimental data supporting carrier function of P3, P4, and P5 is currently not available. However, as demonstrated for SOAT, not all members of the SLC10 family are bile acid transporters. SOAT specifically transports steroid sulfates such as oestrone-3-sulfate and dehydroepiandrosterone sulfate in a sodium-dependent manner, and is considered to play an important role for the cellular delivery of these prohormones in testes, placenta, adrenal gland and probably other peripheral tissues. ASBT and SOAT are the most homologous members of the SLC10 family, with high sequence similarity ( approximately 70%) and almost identical gene structures. Phylogenetic analyses of the SLC10 family revealed that ASBT and SOAT genes emerged from a common ancestor gene. Structure-activity relationships of NTCP, ASBT and SOAT are discussed at the amino acid sequence level. Based on the high structural homology between ASBT and SOAT, pharmacological inhibitors of the ASBT, which are currently being tested in clinical trials for cholesterol-lowering therapy, should be evaluated for their cross-reactivity with SOAT.

摘要

溶质载体家族10(SLC10)包含两种钠依赖性胆汁酸转运蛋白,即钠/牛磺胆酸盐共转运多肽(NTCP;SLC10A1)和顶端钠依赖性胆汁酸转运蛋白(ASBT;SLC10A2)。这些载体主要参与胆汁酸肝肠循环的维持,介导胆汁酸通过肝脏(NTCP)和肠道(ASBT)膜屏障进行主动转运的第一步。最近,描述了SLC10家族的四个新成员,分别称为P3(SLC10A3)、P4(SLC10A4)、P5(SLC10A5)和钠依赖性有机阴离子转运蛋白(SOAT;SLC10A6)。目前尚无支持P3、P4和P5载体功能的实验数据。然而,正如SOAT所显示的那样,SLC10家族并非所有成员都是胆汁酸转运蛋白。SOAT以钠依赖性方式特异性转运类固醇硫酸盐,如雌酮-3-硫酸盐和硫酸脱氢表雄酮,被认为在睾丸、胎盘、肾上腺以及可能的其他外周组织中这些前体激素的细胞递送中起重要作用。ASBT和SOAT是SLC10家族中同源性最高的成员,具有高度的序列相似性(约70%)和几乎相同的基因结构。SLC10家族的系统发育分析表明,ASBT和SOAT基因起源于一个共同的祖先基因。在氨基酸序列水平上讨论了NTCP、ASBT和SOAT的构效关系。基于ASBT和SOAT之间的高度结构同源性,目前正在临床试验中用于降胆固醇治疗测试的ASBT药理抑制剂,应评估其与SOAT的交叉反应性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验